Industry reports
Editor highlights

Drug and Medication Analysis & Statistics in Europe Countries, April 2014

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

1-50 of about 1 600 reports
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We retain our negative outlook for the pharmaceutical industry in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Corruption continues to be a major problem within state healthcare services in Serbia. The government are taking measures to tackle the issue but the pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Russia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: On the positive side, Russia’s pharmaceutical industry should regain double-digit US dollar growth from 2013 and the approval of the country’s entry to the ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Moldova’s pharmaceutical industry recorded stronger growth in 2011, but its small industry size and its status as the poorest countries in Europe limit its attractiveness as a destination ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Spain Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Spain Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Firms with significant exposure to debt-ridden European industry s will be hard hit by government austerity measures across the region, particularly by pharmaceutical price erosion mechanisms. ...

  • Industries : Drug and Medication
  • Countries : Spain
Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: The expected growth of the Switzerland’s ageing population over the next 50 years will have an unprecedented impact on the demand for healthcare. The elderly require more medical check-ups ...

  • Industries : Drug and Medication
  • Countries : Switzerland
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We continue to believe the Belarusian pharmaceutical industry has long-term potential due to the country’s favourable geographic position, demographic profile ...

  • Industries : Drug and Medication
  • Countries : Belarus
Finland Pharmaceuticals and Healthcare Report Q2 2014

Finland Pharmaceuticals and Healthcare Report Q2 2014

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Pharmaceutical companies operating in Finland will continue to be targets of cost-containment policies and experience more price erosions and generic competition. ...

  • Industries : Drug and Medication
  • Countries : Finland
Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Ukraine Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: While we continue to see huge potential in the Ukrainian pharmaceutical industry, we are pessimistic with regard to short- and medium-term stability in the industry place. In particular, we ...

  • Industries : Drug and Medication
  • Countries : Ukraine
Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Following the resignation of Emil Boc and his government in February 2012, there is now considerable uncertainty with regard to reform of the Romanian healthcare segment . In particular, draft ...

  • Industries : Drug and Medication
  • Countries : Romania
Estonia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Estonia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Estonia’s pharmaceutical industry will remain of marginal interest to multinationals given its small population and a modest growth outlook. We expect the industry to post a five-year compound ...

  • Industries : Drug and Medication
  • Countries : Estonia
Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Despite the threat of austerity measures and the government's focus on cost-containment within the pharmaceuticals and healthcare segment, as well as the impact of generic competition as a result ...

  • Industries : Drug and Medication
  • Countries : Germany
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Slovenia's pharmaceutical industry outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised projections have led us to adjust our drug industry projections ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Italy Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Italy Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: The pharmaceuticals and healthcare segment will be a target of further cost containment, particularly as National Health System (SSN) data for H111, which shows a decline in spending, highlights ...

  • Industries : Drug and Medication
  • Countries : Italy
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Some changes have been made to the original March 2011 proposal to reduce costs in the pharmaceutical industry, representing moderately good news for drugmakers. However, this development will ...

  • Industries : Drug and Medication
  • Countries : Hungary
Sweden Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Sweden Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Sweden’s high public expenditure on health (SEK252bn, or US Dollar 39bn, in 2011), accounting for 79% of total healthcare expenditure) is a major factor in making it an attractive place to ...

  • Industries : Drug and Medication
  • Countries : Sweden
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals relative to other Western Europe ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Poland Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Poland Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: It is worth reiterating our view that while 2012 is set to be a challenging year for drugmakers operating in Poland, we do not believe the impact of the Drug Reimbursement Act will lead to an ...

  • Industries : Drug and Medication
  • Countries : Poland
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Despite a contraction in pharmaceutical prices, Latvia's pharmaceutical industry performed strongly in first nine months of 2011, which has led to upward revisions to our outlook for 2011 and ...

  • Industries : Drug and Medication
  • Countries : Latvia
Austria Pharmaceuticals and Healthcare Report Q2 2014

Austria Pharmaceuticals and Healthcare Report Q2 2014

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We believe Austria's pharmaceutical spending will post weak growth over the medium term, due to the state's need to contain fiscal deficits. Although an improving ...

  • Industries : Drug and Medication
  • Countries : Austria
Croatia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Based on Croatia’s deteriorating macroeconomic outlook, combined with our expectations that the new Kukuriku coalition government will pursue more severe austerity measures and the fact the ...

  • Industries : Drug and Medication
  • Countries : Croatia
Ireland Business Projection Industry Update Quarter 2 2012

Ireland Business Projection Industry Update Quarter 2 2012

  • $ 1 208
  • Industry report
  • January 2014
  • by Business Monitor International

Ireland’s economy will post negative growth in 2012 as fiscal austerity, household deleveraging and a recession in Europe weigh on activity. We projection real Gross Domestic Product to contract by 0.5% ...

  • Industries : Drug and Medication
  • Countries : Ireland
Switzerland Business Projection Industry Update Quarter 2 2012

Switzerland Business Projection Industry Update Quarter 2 2012

  • $ 1 208
  • Industry report
  • January 2014
  • by Business Monitor International

We have revised our 2012 projections for Swiss real Gross Domestic Product growth. Following estimated 2011 growth of 1.9%, our significantly bleaker outlook for the global economy means we now projection ...

  • Industries : Drug and Medication
  • Countries : Switzerland
Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2014
  • by Business Monitor International

BMI View: Demographic considerations – in combination with concerted cost-containment pressures that form part of fiscal austerity measures – will continue to hamper the development of the Lithuanian ...

  • Industries : Drug and Medication
  • Countries : Lithuania
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2014
  • by Business Monitor International

BMI View: While we lowered our projections for Hungary's pharmaceutical industry in response to the government's structural reform programme at the start of 2011, we continue to believe the reported magnitude ...

  • Industries : Drug and Medication
  • Countries : Hungary
United Kingdom Pharmaceuticals and Healthcare Report Q1 2014

United Kingdom Pharmaceuticals and Healthcare Report Q1 2014

  • $ 1 300
  • Industry report
  • January 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The UK government's implementation of an almost 4% price cut on medicines in 2014, under a five-year agreement to slow inflation in the GBP11bn (US$15bn) annual ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2014
  • by Business Monitor International

BMI View: It is beyond doubt that drugmakers in Greece – particularly domestic producers primarily exposed to their home industry – are faced with the most challenging operating environment in Europe. ...

  • Industries : Drug and Medication
  • Countries : Greece
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • January 2014
  • by Business Monitor International

The Czech Republic retains its pole position in BMI’s Q111 Regional Business Environment Ratings (BERs) for Emerging Europe. In our global table, the Czech Republic moved upward, placing 12th, now being ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2014
  • by Business Monitor International

BMI View: The introduction of a revised claw-back mechanism in Romania has angered drugmakers operating in the industry . BMI believes the current form of the legislation is overly simplistic and punishes ...

  • Industries : Drug and Medication
  • Countries : Romania
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2014
  • by Business Monitor International

BMI View: The Belarusian pharmaceutical industry has strong long-term potential given its position bordering the EU and Russia, its demographic profile and still low per capita spending on pharmaceuticals. ...

  • Industries : Drug and Medication
  • Countries : Belarus

» Read our Company Profiles

2 Companies

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.